NCT00282568View on ClinicalTrials.gov

A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients

PHASE2CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

August 31, 2002

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Kidney Transplantation
Interventions
DRUG

Tacrolimus Modified Release (MR)

Oral

DRUG

tacrolimus

Oral

Trial Locations (9)

33136

Miami

45267

Cincinnati

53226

Milwaukee

53792

Madison

55455

Minneapolis

97239

Portland

Unknown

San Diego

T6G 2B7

Edmonton

M5C 2T2

Toronto

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT00282568 - A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Kidney Transplant Patients | Biotech Hunter | Biotech Hunter